Ropivacaine Hydrochloride In · 3,090 days since initial FDA posting
Brand: ROPIVACAINE HYDROCHLORIDE
FDA lists Ropivacaine Hydrochloride In as Active Shortage (InfoRLife SA).
Availability on file: Available
Ropivacaine Hydrochloride Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Ropivacaine Hydrochloride Injection
- Manufacturer
- InfoRLife SA
- Dosage Form
- Injection
- Presentation
- Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87)
- Package NDC
- 25021-652-87
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Mar 27, 2018
- Last Updated
- Nov 13, 2025
- Therapeutic Category
- Anesthesia
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Marketed by Sagent Pharmaceuticals
Nearby, Other Ropivacaine Shortage Records
Ropivacaine Hydrochloride Injection
InfoRLife SA
Injection
Ropivacaine Hydrochloride Injection
InfoRLife SA
Injection
Ropivacaine Hydrochloride Injection
InfoRLife SA
Injection
Ropivacaine Hydrochloride Injection
InfoRLife SA
Injection
Ropivacaine Hydrochloride Injection
InfoRLife SA
Injection
Ropivacaine Hydrochloride Injection
Somerset Therapeutics, LLC
Injection
FDA reason on file: Marketed by Sagent Pharmaceuticals. General shortage guidance lives on the tracker hub.